These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38615670)

  • 1. Prognostic Effects of RASSF1A, BRCA1, APC, and p16 Promoter Methylation in Ovarian Cancer: A Meta-Analysis.
    Chen C; Zhu Y; Zhang H; Xiao L
    Gynecol Obstet Invest; 2024; 89(5):363-375. PubMed ID: 38615670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter hypermethylation of p16, BRCA1 and RASSF1A genes in triple-negative breast cancer patients from Serbia.
    Kozomara Z; Supic G; Krivokuca A; Magic Z; Dzodic R; Milovanovic Z; Brankovic-Magic M
    J BUON; 2018; 23(3):684-691. PubMed ID: 30003738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of methylated GSTP1, p16, ESR1 and PITX2 in patients with breast cancer: A systematic meta-analysis under the guideline of PRISMA.
    Sheng X; Guo Y; Lu Y
    Medicine (Baltimore); 2017 Jul; 96(28):e7476. PubMed ID: 28700487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant Promoter Hypermethylation of RASSF1a and BRCA1 in Circulating Cell-Free Tumor DNA Serves as a Biomarker of Ovarian Carcinoma.
    S SK; Swamy SN; Premalatha CS; Pallavi VR; Gawari R
    Asian Pac J Cancer Prev; 2019 Oct; 20(10):3001-3005. PubMed ID: 31653147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter Methylation of BRCA1, DAPK1 and RASSF1A is Associated with Increased Mortality among Indian Women with Breast Cancer.
    Yadav P; Masroor M; Nandi K; Kaza RCM; Jain SK; Khurana N; Saxena A
    Asian Pac J Cancer Prev; 2018 Feb; 19(2):443-448. PubMed ID: 29480000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1 Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-Analysis.
    Kalachand RD; Stordal B; Madden S; Chandler B; Cunningham J; Goode EL; Ruscito I; Braicu EI; Sehouli J; Ignatov A; Yu H; Katsaros D; Mills GB; Lu KH; Carey MS; Timms KM; Kupryjanczyk J; Rzepecka IK; Podgorska A; McAlpine JN; Swisher EM; Bernards SS; O'Riain C; O'Toole S; O'Leary JJ; Bowtell DD; Thomas DM; Prieske K; Joosse SA; Woelber L; Chaudhry P; Häfner N; Runnebaum IB; Hennessy BT
    J Natl Cancer Inst; 2020 Dec; 112(12):1190-1203. PubMed ID: 32413141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter hypermethylation profile of ovarian epithelial neoplasms.
    Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO
    Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter methylations of RASSF1A and p16 is associated with clinicopathological features in lung cancers.
    Han JC; Xu F; Chen N; Qi GB; Wei YJ; Li HB; Zhang YJ; Li JH; Wang XL; Xu W; Li XF; Jin LF; Jia JY; Ma ZS
    J Cancer Res Ther; 2016; 12(1):340-9. PubMed ID: 27072261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation profile of BRCA1, RASSF1A and ER in Vietnamese women with ovarian cancer.
    Vo LT; Thuan TB; Thu DM; Uyen NQ; Ha NT; To TV
    Asian Pac J Cancer Prev; 2013; 14(12):7713-8. PubMed ID: 24460357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation Analysis of BRCA1 and APC in Breast Cancer and It's Relationship to Clinicopathological Features.
    Shakeri H; Fakhrjou A; Nikanfar A; Mohaddes-Ardebili SM
    Clin Lab; 2016 Dec; 62(12):2333-2337. PubMed ID: 28164568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.
    Balgkouranidou I; Matthaios D; Karayiannakis A; Bolanaki H; Michailidis P; Xenidis N; Amarantidis K; Chelis L; Trypsianis G; Chatzaki E; Lianidou ES; Kakolyris S
    Mutat Res; 2015 Aug; 778():46-51. PubMed ID: 26073472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequent promoter hypermethylation of the APC and RASSF1A tumour suppressors in parathyroid tumours.
    Juhlin CC; Kiss NB; Villablanca A; Haglund F; Nordenström J; Höög A; Larsson C
    PLoS One; 2010 Mar; 5(3):e9472. PubMed ID: 20208994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RASSF1A promoter methylation in high-grade serous ovarian cancer: A direct comparison study in primary tumors, adjacent morphologically tumor cell-free tissues and paired circulating tumor DNA.
    Giannopoulou L; Chebouti I; Pavlakis K; Kasimir-Bauer S; Lianidou ES
    Oncotarget; 2017 Mar; 8(13):21429-21443. PubMed ID: 28206954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter methylation as biomarkers for diagnosis of melanoma: A systematic review and meta-analysis.
    Guo Y; Long J; Lei S
    J Cell Physiol; 2019 May; 234(5):7356-7367. PubMed ID: 30370527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis demonstrates no association between p16
    Jiang Y; Yan F; Liang L; Wan Y; Liu J; Cheng W
    Arch Gynecol Obstet; 2017 Mar; 295(3):697-704. PubMed ID: 28000027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of tissue promoter methylation levels of APC, TGFβ2, HOXD3 and RASSF1A with prostate cancer progression.
    Liu L; Kron KJ; Pethe VV; Demetrashvili N; Nesbitt ME; Trachtenberg J; Ozcelik H; Fleshner NE; Briollais L; van der Kwast TH; Bapat B
    Int J Cancer; 2011 Nov; 129(10):2454-62. PubMed ID: 21207416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between RASSF1A promoter methylation and ovarian cancer: a meta-analysis.
    Shi H; Li Y; Wang X; Lu C; Yang L; Gu C; Xiong J; Huang Y; Wang S; Lu M
    PLoS One; 2013; 8(10):e76787. PubMed ID: 24116157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypermethylation of p16 and APC in gastrointestinal cancer patients.
    Erdem B; Küçükyıldırım S; Sağlar E; Polat Z; Mergen H
    Turk J Gastroenterol; 2014 Oct; 25(5):512-7. PubMed ID: 25417611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of RASSF1A promoter methylation in the pathogenesis of ovarian cancer: a meta-analysis.
    Si JG; Su YY; Han YH; Chen RH
    Genet Test Mol Biomarkers; 2014 Jun; 18(6):394-402. PubMed ID: 24665911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic role of RASSF1A promoter methylation in breast cancer: a meta-analysis of published data.
    Jiang Y; Cui L; Chen WD; Shen SH; Ding LD
    PLoS One; 2012; 7(5):e36780. PubMed ID: 22615811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.